Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 4/20 | 0.39 |
| ▸ | AGTR2 | P50052 | 4/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9707713 | 0.90 | AGTR1 (0.43) | AGTR1AGTR2 | |
| SCHEMBL9707370 | 0.89 | PPARG (0.36) | AGTR1AGTR2MEN1KMT2ANPC1 | |
| SCHEMBL9707747 | 0.88 | KDM4E (0.44) | AGTR1AGTR2KDM4EHPGD | |
| SCHEMBL9707897 | 0.88 | AGTR1 (0.44) | AGTR1AGTR2 | |
| SCHEMBL9708298 | 0.88 | ADORA2B (0.40) | AGTR1AGTR2MEN1KMT2AKDM4E | |
| SCHEMBL9707610 | 0.88 | AGTR1 (0.36) | AGTR1AGTR2 | |
| SCHEMBL9707625 | 0.87 | KDM4E (0.41) | AGTR1AGTR2MEN1KMT2AKDM4E | |
| SCHEMBL9707621 | 0.87 | AGTR1 (0.49) | AGTR1AGTR2 | |
| SCHEMBL9708402 | 0.86 | AGTR1 (0.46) | AGTR1AGTR2 | |
| SCHEMBL9708605 | 0.86 | ADORA2B (0.42) | AGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1992007852-A1 | BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1992-05-14 | — | — | WO | disclosed |